New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 11, 2012
12:13 EDTVRTXVertex announced data on on ALS-2200 are being presented at AASLD
Vertex Pharmaceuticals announced that data on ALS-2200, VX-135, an oral medicine Vertex is developing for the treatment of hepatitis C, are being presented for the first time at The Liver Meeting, the 63rd Annual Meeting of the American Association for the Study of Liver Diseases, AASLD. Data from viral kinetic study showed rapid reduction of HCV RNA with ALS-2200 (VX-135), Vertex’s oral nucleotide analogue in development for the treatment of hepatitis C.
News For VRTX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 29, 2015
16:10 EDTVRTXVertex raises 2015 KALYDECO sales outlook to $575M-$590M
Subscribe for More Information
16:09 EDTVRTXVertex reports Q2 EPS (54c), consensus (58c)
Reports Q2 revenue $166.1M, consensus $149.7M. Reports KALYDECO product revenue $154.9M vs. $113.1M last year.
15:59 EDTVRTXNotable companies reporting after market close
Notable companies reporting after the market close, with earnings consensus, include Facebook (FB), consensus 47c... MetLife (MET), consensus $1.48... Williams (WMB), consensus 24c... Vertex (VRTX), consensus (58c)... O'Reilly Automotive (ORLY), consensus $2.26... NXP Semiconductors (NXPI), consensus $1.37... Marriott (MAR), consensus 81c... Fiserv (FISV), consensus 94c... Western Digital (WDC), consensus $1.45... SBA Communications (SBAC), consensus 9c... Whole Foods (WFM), consensus 45c... Lincoln National (LNC), consensus $1.53... Lam Research (LRCX), consensus $1.47... ServiceNow (NOW), consensus (2c)... Qorvo (QRVO), consensus $1.06... Hologic (HOLX), consensus 39c.
15:08 EDTVRTXNotable companies reporting after market close
Subscribe for More Information
July 28, 2015
07:20 EDTVRTXBrookings Institute to hold a public meeting
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use